2-(N-benzylanilino)ethyl 3-aminobut-2-enoate | CAS:111011-79-1

We serve 2-(N-benzylanilino)ethyl 3-aminobut-2-enoate CAS:111011-79-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(N-benzylanilino)ethyl 3-aminobut-2-enoate

Chemical Name: 2-(N-benzylanilino)ethyl 3-aminobut-2-enoate
CAS.NO:  111011-79-1
Synonyms:
Efonidipine Hydrochloride

Molecular Formula: C19H22N2O2
Molecular Weight: 310.39000

Physical and Chemical Properties:

Specification:
Appearance: /
Purity:≥98.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Efonidipine CAS:111011-76-8.



Contact us for information like 2-(N-benzylanilino)ethyl 3-aminobut-2-enoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Efonidipine Hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(N-benzylanilino)ethyl 3-aminobut-2-enoate Use and application,2-(N-benzylanilino)ethyl 3-aminobut-2-enoate technical grade,usp/ep/jp grade.


Related News: “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.N-Cyano-N-Methyl-Ethanimidamide manufacturer After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.1-(2-Chlorophenyl)-3-methyl-2-pyrazolin-5-one supplier Others wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.4-Fluoro-2-nitroanisole vendor Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.